DB视讯

      Improve patients' lives by timely providing them with

      quality and affordable protein therapeutics

      Honor
      • 2025

        Xueqiu Annual Golden List – 2024 Most Promising Company

      • 2025

        2024 JRJ "Golden Wisdom Award" – Outstanding Pharmaceutical & Biotechnology Industry Excellence Award

      • 2025

        2024 Pudong New Area Outstanding Contribution Award

      • 2025

        2024 Xuhui Top 100 Enterprises Contribution Award

      • 2024
        Pharmcube 2023 Top 15 Business Development Innovators in China
      • 2024
        Outstanding Contributions to Economy
      • 2024
        2024 Shanghai Top 100 Hard Tech Companies List
      • 2024
        2024 Shanghai Top 100 Most Promising SME Brands
      • 2023
        2022 Health Communication - Creative Award
      • 2023
        2022 Health Communication - Social Responsibility Award
      • 2023
        Outstanding Contribution Award for Private Enterprise in Xuhui District
      • 2023
        Top 10 Most Influential Antibody Company in 2023
      • 2023
        2022 Chinese Innovative Antibody Company Top 30
      • 2023
        BioCon Awards - Biopharmaceutical Enterprise Star in 2022
      • 2023
        2022 Shanghai Biopharmaceutical "New Excellent Medical Device" Product Catalog
      • 2023
        2022 China Pharmaceutial Social Responsility Media Watch-Public Welfare Pillar
      • 2023
        Brand of High-Quality Pharmaceutical Development Achievements in China
      • 2023
        Enterprise of High-Quality Pharmaceutical Development Achievements in China
      • 2023
        Shanghai Drug Manufacturer Credit Assessment Grade A in 2022
      • 2023
        2022 Outstanding Scientific Innovation Enterprise Award and Top100 Enter-prises of Contribution Award
      • 2023
        Advanced Unit for Harmonious Creation in 2022
      • 2023
        The Gold Walking Stick Award 「Top 10 Innovative Pharmaceutical Enterprises in 2022」
      • 2023
        2022 Wind ESG Hong Kong Stock Best Practice Award
      • 2022
        2022 The 18th China Golden Awards For Excellence In Public Relations
      • 2022
        HR Asia Best Companies to Work For in Asia 2022
      • 2022
        2022 JRJ GoldenWis Award 
      • 2022
        2022 The Reputation list of China Listed Companies
      • 2022
        The 7th "Jin Gang Stocks" Most Valuable Pharmaceutical and Medical Company
      • 2022
        2022 Guruclub Greater China Best Listed Company Awards 
      • 2022
        2022 Innovative Product Award - HANSIZHUANG
      • 2022
        Certificate of For Good Enterprise
      • 2022
        2022 Golden Flag Award - Public Relations
      • 2022
        2022 Changchun Award –「Pharmaceutical R&D Enterprise of the Year」
      • 2022
        Business Development of the Yea
      • 2022
        2022 Top100 Chinese Pharmaceutical Innovative Enterprises
      • 2022
        Pudong New Area District R&D Institution Enterprise
      • 2022
        Top Ten Public Welfare Enterprises of "China Health Public Welfare Star" in 2021
      • 2022
        Ranked 10th in Top 15 Biotechs of the 9th Hong Kong Stocks Top 100 Biotech List
      • 2022
        The 27th of Shanghai Enterprise Technology Centers
      • 2022
        The 6th "Jin Gang Stocks"  Most Valuable Pharmaceutical and Medical Company
      • 2021
        The 4th ONE FOSUN Charity Week 2021 “Top Ten Charity Projects”
      • 2021
        Shanghai Drug Manufacturer Credit Rating A in 2021
      • 2021
        2021 "Jinzhi Award" Excellent Business Practice Award in China Biopharmaceutical Industry
      • 2021
        Top 10 Independent Innovation of Shanghai High-tech Achievement Transformation Project
      • 2021
        2021 Top 100 Chinese Pharmaceutical Innovation Companies, the First Tier
      • 2021
        Pudong New District Strong-growth Compnay
      • 2021
        Golden Flag Award for CSR
      • 2021
        2021 Changchun Award
      • 2021
        The 17th China Golden Awards for Excellence in PR
      • 2021
        The Hong Kong Management Association "Certificate of Excellence in ESG Reporting"
      • 2021
        Innovation Billboard "The Best Business Development"
      • 2021
        Shanghai Worker Pioneer 汉曲优 Core Project Team
      • 2021
        Chinese Antibody Drug Enterprise Top 30 Innovation Star in 2020
      • 2021
        SPPA "Famous and Excellent Products in 2020"  - 汉利康 Rituximab & 汉曲优 Trastuzumab
      • 2021
        MENET "2020 TOP20 China Biopharmaceutical Company"
      • 2021
        Red Cross Society of China Fujian Branch "Honor Certificate for Charity"
      • 2021
        National Worker Pioneer (Henlius HLX01 - Project Core Team)
      • 2021
        Global Health & Pharma Magazine "Most Innovative Global Biopharmaceutical Company 2021"
      • 2021
        Shanghai Anti-tumour Biologic Engineering and Technology Research Centre
      • 2021
        The 13th China Health Annual Forum Top 10 New Medicine(汉曲优®)
      • 2020
        Shanghai Model Group
      • 2020
        5th Social Value Co-creation Outstanding Award
      • 2020
        Gelonghui "2020 The Best Listing Company - Best Information Disclosure Award"
      • 2020
        CIPRA "The 16th China Global Awards for Excellence in Public Relations Social Responsibility Bronze Award"
      • 2020
        eMedClub PharmaBIGStar - "Top 50 Most Innovative Companies of Chinese Biomedicine in 2020"
      • 2020
        JRJ.COM "Jinzhi Award - The Most Valued Top 10 in Biopharmaceutical Industry"
      • 2020
        CNPIIC "China Innovation New Power in Pharmaceutical Industry"
      • 2020

        Changchun Award "2020 Innovative Pharmaceutical Enterprise"

      • 2020
        China Pharmaceutical Brand with Greatest Growth Potential - 汉利康® HLX01 Rituximab Injection
      • 2020
        2019 China Biopharmaceutical Company Top 20
      • 2020
        EBC Awards "The Most Influential Enterprise in Biopharmaceutical Industry"
      • 2020
        China Youth "2019 PR Influence Top 20 Startup in Pharmaceutical Industry"
      • 2019
        ZJ Science City "Outstanding Listed Company"
      • 2019
        The 4th Jin Gang Gu "The Most Valuable Pharmaceutical Enterprise"
      • 2019
        The 8th Charity Festival  "Innovative CSR Activity Award"
      • 2019

        Sina Medical - Wisdom Growing Forum "The Most Valued Biopharmaceutical Enterprise"

      • 2019

        Sina Medical - Wisdom Growing Forum "The Best Charity Event in BioPharm Industry"

      • 2019
        Vcbeat Net "Future Healthcare VB 100"
      • 2019
        ONE FOSUN CSR Week "Special CSR Activity - Understanding Lymphoma: A Medical Education Charity Event"
      • 2019

        Global Generics & Biosimilars Awards  "Company of the Year,Asia Pacific - Finalist"

      • 2019
        Shanghai Worker Pioneer HLX01 Core Project Team
      • 2019
        JRJ.com "Future Company of BioPharm Industry"
      • 2019
        Forbes China "The Most Innovative Companies in China"
      • 2019
        China Financial Market "Excellent Biopharmaceutical Enterprise" 
      • 2019
        Global Generics & Biosimilars Awards 2019 "Biosimilar Initiative of the Year"  - 汉利康®
      • 2019

        ZCCS "The Most Innovative Award"

      • 2019
        Equal Ocean "China Healthcare Industry Award - the Best Innovative Biopharmaceutical Enterprise"
      • 2019
        Frost & Sullivan  "China New Economy Award - Excellence in Innovation"
      • 2019
        MENET, Medicine Economic Reporter "Top 20 Biopharmaceutical Company in China"
      • 2019

        The 8th China Finance Summit "The Most Innovative Enterprise"

      • 2019

        Trade Union of Xuhui District, Science and Technology Commission of Xuhui District "2019 Xuhui District Innovation Centre for Science & Technology Contest Finalist"

      • 2018
        China Entrepreneur "Future Stars"
      • 2018

        Venture 50 "China Top 50 Investments for Value "

      • 2018

        Innovative Startup Top 20 in Pudong New Area

      • 2018

        The 7th China Finance Summit "The Most Innovative Enterprise"

      • 2018

        Ernst & Young "The Most Promising Enterprises in China"

      • 2018

        Science and Technology Innovation Award for Songjiang Manufacturing Facility

      • 2018

        Haoyue Capital "Annual Best Venture Case in Biopharm "

      • 2018
        Chinese Pharmaceutical Association "The Fast-growing Pharmaceutical Enterprise of Science and Technology Innovation in 2018"
      • 2018

        China Business Journal "The Most Innovative Enterprise in Health Industry"

      • 2018

        China Healthcare Consulting Group(CHC)-CITIC Securities "2017 Top Venture in Medical and Health"

      • 2018

        Life Science & Healthcare Unicorn Enterprise in Pudong New Area, Shanghai

      • 2018
        Social Responsibility Conference "2018 Branding Award"
      • 2018

        BioPharma "Asia Biotech of 2017"

      • 2018
         Vcbeat Net "Top of 2018 Future Medicine 100"
      • 2018
        Sina Medical "The Most Innovative Enterprise in Pharmaceutical Industry in 2018 China"
      • 2017

        Specialized & Innovative SME

      • 2017

        Deloitte Touche Tohmatsu "2017 Future Star in the China Pharma Industry"

      • 2017

        IMAPAC "Best Bioprocessing Excellence in China"

      • 2017

        IMAPAC "Leading Innovations in Cutting-edge Technologies for Novel mAb Development & Production"

      • 2017
        Life Science & Healthcare Unicorn Enterprise in China
      • 2016

        Hign and New Technology Enterprises

      Listed Enterprise 2023

      Bloomberg Businessweek

      Shanghai Innovative Enterprise Headquarters

      Shanghai Municipal Government

      2024 Shanghai Top 100 Hard-Tech Companies List

      SMCEI

      Best Companies to Work for in Asia 2023

      HR Asia

      Biosimilar Initiative of the Year (HANLIKANG)

      GGB Awards